European Commission approves Merck’s pneumococcal vaccine Vaxneuvance, Health News, ET HealthWorld
KENILWORTH, N.J : European Commission has granted approval to pharmaceutical company Merck for its Pneumococcal 15-valent Conjugate Vaccine, Vaxneuvance™, for active immunization to prevent the disease. The approval allows the…

